HK1255683A1 - 用於在特定目標群體中減少酒精消耗的納美芬 - Google Patents

用於在特定目標群體中減少酒精消耗的納美芬

Info

Publication number
HK1255683A1
HK1255683A1 HK18114830.5A HK18114830A HK1255683A1 HK 1255683 A1 HK1255683 A1 HK 1255683A1 HK 18114830 A HK18114830 A HK 18114830A HK 1255683 A1 HK1255683 A1 HK 1255683A1
Authority
HK
Hong Kong
Prior art keywords
nalmefene
reduction
specific target
alcohol consumption
target populations
Prior art date
Application number
HK18114830.5A
Other languages
English (en)
Inventor
L‧托魯普
A‧阿巴利基
A‧布拉德斯特拉姆
C‧佩爾松
D‧繆黎恩
P‧索倫森
T‧J‧延森
J‧B‧奧斯特格爾德
Original Assignee
H‧隆德貝克有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1255683(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H‧隆德貝克有限公司 filed Critical H‧隆德貝克有限公司
Publication of HK1255683A1 publication Critical patent/HK1255683A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HK18114830.5A 2012-06-27 2018-11-20 用於在特定目標群體中減少酒精消耗的納美芬 HK1255683A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261664804P 2012-06-27 2012-06-27
US201261721539P 2012-11-02 2012-11-02
US201261736740P 2012-12-13 2012-12-13
US201361788810P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
HK1255683A1 true HK1255683A1 (zh) 2019-08-23

Family

ID=48703496

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15108930.9A HK1208185A1 (zh) 2012-06-27 2015-09-11 用於在特定目標群體中減少酒精消耗的納美芬
HK18114830.5A HK1255683A1 (zh) 2012-06-27 2018-11-20 用於在特定目標群體中減少酒精消耗的納美芬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15108930.9A HK1208185A1 (zh) 2012-06-27 2015-09-11 用於在特定目標群體中減少酒精消耗的納美芬

Country Status (35)

Country Link
US (4) US20140005216A1 (zh)
EP (4) EP3138564B1 (zh)
JP (3) JP6258933B2 (zh)
KR (1) KR20150023396A (zh)
CN (1) CN104411313A (zh)
AU (1) AU2013283281B2 (zh)
BR (1) BR112014032555A2 (zh)
CA (1) CA2874703C (zh)
CL (1) CL2014003484A1 (zh)
CO (1) CO7160087A2 (zh)
CY (3) CY1118579T1 (zh)
DK (3) DK3138564T3 (zh)
EA (1) EA029908B1 (zh)
ES (3) ES2663532T3 (zh)
FI (1) FI3345604T3 (zh)
HK (2) HK1208185A1 (zh)
HR (3) HRP20230762T8 (zh)
HU (3) HUE063313T2 (zh)
IL (1) IL236035B (zh)
LT (3) LT3345604T (zh)
ME (2) ME02587B (zh)
MX (1) MX371373B (zh)
MY (1) MY166914A (zh)
NZ (1) NZ702191A (zh)
PH (1) PH12014502798A1 (zh)
PL (3) PL3138564T3 (zh)
PT (3) PT3138564T (zh)
RS (2) RS57046B1 (zh)
RU (1) RU2665373C2 (zh)
SG (1) SG11201408704WA (zh)
SI (3) SI3345604T1 (zh)
SM (1) SMT201600471B (zh)
UA (1) UA114199C2 (zh)
WO (1) WO2014001427A1 (zh)
ZA (1) ZA201409525B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
JP6419780B2 (ja) * 2013-04-17 2018-11-07 ハー・ルンドベック・アクチエゼルスカベット 睡眠障害患者の治療のためのナルメフェン
AU2015250611A1 (en) 2014-04-22 2016-11-24 H. Lundbeck A/S Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
US20170071590A1 (en) * 2015-09-10 2017-03-16 Suture Armor Llc Suture anchor
KR102699603B1 (ko) 2018-04-20 2024-08-29 삼성전자주식회사 반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
JP2005508888A (ja) * 2001-08-14 2005-04-07 バイオティ セラピーズ コーポレイション アルコール依存症またはアルコール中毒を治療する方法
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
RS54599B1 (en) 2009-05-25 2016-08-31 H. Lundbeck A/S PREPARATION OF NALMEPHEN HYDROCHLORIDE FROM NALTREXONE
AP3415A (en) 2010-11-05 2015-09-30 Lundbeck & Co As H Method for manufacturing of naltrexone
JP5738470B2 (ja) 2011-03-31 2015-06-24 イムネクス ファーマ イラチュ サナイ ヴェ ティジャレット ア．シェ．Ｉｍｕｎｅｋｓ Ｆａｒｍａ Ｉｌａｃ Ｓａｎａｙｉ Ｖｅ Ｔｉｃａｒｅｔ Ａ．Ｓ． オピオイド拮抗体組成物、および強皮症の治療のためのその使用
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations

Also Published As

Publication number Publication date
AU2013283281B2 (en) 2017-04-20
US9642849B2 (en) 2017-05-09
NZ702191A (en) 2017-06-30
MY166914A (en) 2018-07-24
HUE063313T2 (hu) 2024-01-28
RS57046B1 (sr) 2018-05-31
US20140005216A1 (en) 2014-01-02
LT3345604T (lt) 2023-08-10
LT3138564T (lt) 2018-04-10
EA201492152A1 (ru) 2015-11-30
CY1120097T1 (el) 2018-12-12
PL2866808T3 (pl) 2017-04-28
SI3345604T1 (sl) 2023-08-31
EP3138564B1 (en) 2018-01-31
MX2014015488A (es) 2015-03-06
ME03030B (me) 2018-10-20
EP3345604A1 (en) 2018-07-11
US10034874B2 (en) 2018-07-31
ES2663532T3 (es) 2018-04-13
SI3138564T1 (en) 2018-04-30
JP2015521647A (ja) 2015-07-30
BR112014032555A2 (pt) 2017-06-27
CA2874703C (en) 2022-08-23
ME02587B (me) 2017-06-20
JP6258933B2 (ja) 2018-01-10
EP3138564A1 (en) 2017-03-08
IL236035A0 (en) 2015-01-29
ZA201409525B (en) 2016-08-31
RS55456B1 (sr) 2017-04-28
ES2950492T3 (es) 2023-10-10
US20180028526A1 (en) 2018-02-01
EP4223296A2 (en) 2023-08-09
CY1126140T1 (el) 2023-11-15
CO7160087A2 (es) 2015-01-15
PT3138564T (pt) 2018-04-03
PT3345604T (pt) 2023-07-17
PH12014502798A1 (en) 2015-02-09
US20160375007A1 (en) 2016-12-29
JP2018039810A (ja) 2018-03-15
DK2866808T3 (en) 2017-01-16
UA114199C2 (uk) 2017-05-10
FI3345604T3 (fi) 2023-07-28
CL2014003484A1 (es) 2015-02-27
HRP20230762T1 (hr) 2023-10-13
IL236035B (en) 2018-12-31
AU2013283281A1 (en) 2014-12-11
KR20150023396A (ko) 2015-03-05
EA029908B1 (ru) 2018-05-31
PT2866808T (pt) 2017-01-03
HRP20161717T1 (hr) 2017-02-10
HRP20180363T1 (hr) 2018-04-20
SMT201600471B (it) 2017-03-08
SG11201408704WA (en) 2015-01-29
ES2609122T3 (es) 2017-04-18
DK3345604T3 (da) 2023-07-24
EP2866808B1 (en) 2016-11-02
CY1118579T1 (el) 2017-07-12
HRP20230762T8 (hr) 2024-01-05
LT2866808T (lt) 2017-01-10
EP2866808A1 (en) 2015-05-06
CN104411313A (zh) 2015-03-11
HK1208185A1 (zh) 2016-02-26
WO2014001427A1 (en) 2014-01-03
PL3345604T3 (pl) 2023-08-28
RU2014151156A (ru) 2016-08-20
PL3138564T3 (pl) 2018-06-29
MX371373B (es) 2020-01-28
CA2874703A1 (en) 2014-01-03
HUE036272T2 (hu) 2018-06-28
JP2019163275A (ja) 2019-09-26
HUE031110T2 (en) 2017-06-28
JP6857684B2 (ja) 2021-04-14
RU2665373C2 (ru) 2018-08-29
SI2866808T1 (sl) 2017-01-31
DK3138564T3 (en) 2018-03-26
EP4223296A3 (en) 2023-09-27
US20140005217A1 (en) 2014-01-02
EP3345604B1 (en) 2023-06-07

Similar Documents

Publication Publication Date Title
IL236625B (en) Processes for preparing derivatives of 3-carbonyl-4-hydroxy-isoquinoline and intermediates obtained in these processes
IL236525A0 (en) Antibodies against conserved targets
EP2678677A4 (en) TRANSFORMATION SYSTEM FOR OPTIMIZING FOODS DURING THE CONSUMPTION
EP2815375A4 (en) SYNCHRONIZED USE MODES FOR E-BOOKS
HK1255683A1 (zh) 用於在特定目標群體中減少酒精消耗的納美芬
PT2748562T (pt) Identificação de consumos de serviços
GB201222625D0 (en) Improvements relating to tracking moving objects
GB201501116D0 (en) Improvements to refrigeration systems
GB2505638B (en) Continuous culture
EP2752254A4 (en) ENERGY SAVING DEVICE FOR A ROLLING SYSTEM
EP2591368A4 (en) METHOD FOR DETERMINING ETHANOL CONSUMPTION
GB2492873B (en) Soap Saving system
EP2702462A4 (en) UNAUVIKED WAKING UP
EP2845186A4 (en) EFFECTIVE ANTICRENELING IN ENERGY
EP2909816A4 (en) DETERMINING ENERGY CONSUMPTION FOR A VEHICLE
GB201214566D0 (en) Improvements in and relating to virtualised systems
GB201114034D0 (en) Ashiur ayana ayana woman
GB201110463D0 (en) Energy-efficient device
GB201222657D0 (en) Improvements relating to personal tracking identifiers
GB201012404D0 (en) Taxi beeper
GB201108369D0 (en) Utility columns
AU338684S (en) Bolero
GB201102831D0 (en) Follicle culture